Avantor (AVTR) Cash from Financing Activities (2018 - 2026)
Avantor (AVTR) posted quarterly Cash from Financing Activities of -$112.4 million for Q2 2026, down 1528.99% year-over-year from $7.9 million in Q2 2025, and down 4.85% quarter-over-quarter from -$107.2 million in Q1 2026.
Avantor (AVTR) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Avantor's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$112.4 million for Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 1528.99% year-over-year to -$112.4 million; the TTM figure through Jun 2026 stood at -$588.5 million (up 40.82% YoY), while the FY2025 annual figure was -$409.4 million, up 68.05% from the prior year.
- Cash from Financing Activities for Q2 2026 stood at -$112.4 million, down from -$107.2 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $700000.0 in Q4 2025, with the low at -$755.3 million in Q4 2024.
- The 5-year median for Cash from Financing Activities is -$186.2 million (2023), against an average of -$189.0 million.
- The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities surged 100.09% in 2025, then tumbled 1528.99% in 2026.
- Avantor's Cash from Financing Activities stood at -$81.6 million in 2022, then tumbled by 125.61% to -$184.1 million in 2023, then sank by 310.27% to -$755.3 million in 2024, then soared by 100.09% to $700000.0 in 2025, then plunged by 16157.14% to -$112.4 million in 2026.
- Business Quant data shows AVTR's Cash from Financing Activities at -$112.4 million in Q2 2026, -$107.2 million in Q1 2026, and $700000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Avantor | 9.76 Bn | 9.45 Bn | 537.00 Mn | -112.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -112.40 Mn |
| Jun 30, 2026 | -112.40 Mn |
| Mar 31, 2026 | -107.20 Mn |
| Mar 31, 2026 | -107.20 Mn |
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | -369.60 Mn |
| Sep 30, 2025 | -369.60 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Jun 30, 2025 | -6.90 Mn |
| Mar 31, 2025 | -33.60 Mn |
| Mar 31, 2025 | -33.60 Mn |
| Dec 31, 2024 | -755.30 Mn |
| Dec 31, 2024 | -755.30 Mn |
| Sep 30, 2024 | -198.60 Mn |
| Sep 30, 2024 | -198.60 Mn |
| Jun 30, 2024 | -197.10 Mn |
| Jun 30, 2024 | -197.10 Mn |
| Mar 31, 2024 | -130.20 Mn |
| Mar 31, 2024 | -130.20 Mn |